CNO Financial Group Reports Fourth Quarter and Full Year 2017 Results
The Tax Reform Act will be an ongoing benefit to the company, with the estimated effective tax rate in the 21 to 23 percent range. Excluding the one-time unfavorable impacts of the Tax Reform Act, fourth quarter 2017 net income was
CNO also announced that fourth quarter 2017 net operating income (1) increased to
"CNO had another strong quarter, capping off a solid year highlighted by a double digit increase in operating earnings," said Gary Bhojwani, chief executive officer of CNO. "We experienced good asset growth in our accumulation businesses and saw improvements in nearly all of our Growth Scorecard measures across the firm. We are well positioned to build on our momentum as we continue to implement strategic initiatives that we expect will accelerate growth in our key production metrics."
"While our fourth quarter earnings were negatively impacted by the Tax Reform Act, we expect the ongoing improvements to our income will more than offset the one-time accounting impacts."
Fourth Quarter 2017 Highlights
- First-year collected premiums:
$357.3 million , down 5% from 4Q16 - Total collected premiums:
$940.9 million , down 1% from 4Q16 - New annualized premium ("NAP") (2) for life and health products:
$85.4 million , down 5% from 4Q16 - Annuity collected premiums:
$272.6 million , down 4% from 4Q16 - Annuity account values:
$8.5 billion , up 4% from 4Q16 - Policies inforce of 3.5 million (including third party policies inforce), down 1% from 4Q16
- Net income (loss) per diluted share:
(42) cents in 4Q17 compared to$1.34 in 4Q16 - Net operating income (1) per diluted share:
51 cents in 4Q17 compared to49 cents in 4Q16 - Book value per common share increased to
$29.05 atDecember 31, 2017 from$25.82 atDecember 31, 2016 - Book value per diluted share, excluding accumulated other comprehensive income (loss) (3), was
$21.43 atDecember 31, 2017 compared to$22.02 atDecember 31, 2016 - Unrestricted cash and investments held by our holding company were
$397 million atDecember 31, 2017 compared to$264 million atDecember 31, 2016 - Common stock repurchases of
$27.0 million and dividends of$15.1 million in 4Q17
Full Year 2017 Highlights
- First-year collected premiums:
$1,374.1 million , up 2% from 2016 - Total collected premiums:
$3,688.3 million , up 2% from 2016 - NAP (2) for life and health products:
$332.6 million , down 7% from 2016 - Annuity collected premiums:
$1,031.5 million , up 6% from 2016 - Net income per diluted share:
$1.02 in 2017 compared to$2.01 in 2016 - Net operating income (1) per diluted share:
$1.75 in 2017 compared to$1.47 in 2016 - Common stock repurchases of
$167.1 million and dividends of$59.6 million in 2017 - Consolidated risk-based capital ratio was estimated at 446% at
December 31, 2017 , reflecting estimated statutory operating earnings of$362 million and insurance company dividends to the holding company of$357.7 million during 2017
Quarterly Segment Operating Results |
|||||||
Three months ended |
|||||||
|
|||||||
2017 |
2016 |
||||||
(Dollars in millions, except per share data) |
|||||||
Adjusted EBIT (4): |
|||||||
Bankers Life |
$ |
109.7 |
$ |
138.9 |
|||
Washington National |
23.7 |
29.9 |
|||||
Colonial Penn: |
|||||||
Inforce business (5) |
17.5 |
13.4 |
|||||
New business (5) |
(11.6) |
(8.8) |
|||||
Total Colonial Penn |
5.9 |
4.6 |
|||||
Long-term care in run-off |
.6 |
(3.9) |
|||||
Adjusted EBIT from business segments |
139.9 |
169.5 |
|||||
Corporate Operations, excluding corporate interest expense |
(3.3) |
(23.0) |
|||||
Adjusted EBIT |
136.6 |
146.5 |
|||||
Corporate interest expense |
(11.7) |
(11.5) |
|||||
Operating earnings before taxes |
124.9 |
135.0 |
|||||
Tax expense on operating income |
39.1 |
50.1 |
|||||
Net operating income (1) |
85.8 |
84.9 |
|||||
Net realized investment losses (net of related amortization) |
(2.0) |
(14.8) |
|||||
Fair value changes in embedded derivative liabilities (net of related amortization) |
5.5 |
46.2 |
|||||
Fair value changes related to agent deferred compensation plan |
1.2 |
15.1 |
|||||
Other |
(4.2) |
(.8) |
|||||
Non-operating income (loss) before taxes |
.5 |
45.7 |
|||||
Income tax expense (benefit): |
|||||||
On non-operating income (loss) |
.1 |
16.0 |
|||||
Valuation allowance for deferred tax assets and other tax items |
157.1 |
(119.6) |
|||||
Net non-operating income (loss) |
(156.7) |
149.3 |
|||||
Net income (loss) |
$ |
(70.9) |
$ |
234.2 |
|||
Per diluted share: |
|||||||
Net operating income |
$ |
.51 |
$ |
.49 |
|||
Net realized investment losses (net of related amortization and taxes) |
(.01) |
(.06) |
|||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) |
.02 |
.17 |
|||||
Fair value changes related to agent deferred compensation plan (net of taxes) |
.01 |
.06 |
|||||
Valuation allowance for deferred tax assets and other tax items |
(.94) |
.68 |
|||||
Other |
(.01) |
— |
|||||
Net income (loss) |
$ |
(.42) |
$ |
1.34 |
The following table summarizes the financial impact of significant items on our 4Q17 net operating income (dollars in millions, except per share amounts):
Three months ended |
|||||||||||
|
|||||||||||
Actual results |
Significant items |
Excluding significant items |
|||||||||
Net Operating Income (1): |
|||||||||||
Bankers Life |
$ |
109.7 |
$ |
(10.8) |
$ |
98.9 |
|||||
Washington National |
23.7 |
1.0 |
24.7 |
||||||||
Colonial Penn |
5.9 |
— |
5.9 |
||||||||
Long-term care in run-off |
.6 |
— |
.6 |
||||||||
Adjusted EBIT from business segments |
139.9 |
(9.8) |
130.1 |
||||||||
Corporate Operations, excluding corporate interest expense |
(3.3) |
— |
(3.3) |
||||||||
Adjusted EBIT (4) |
136.6 |
(9.8) |
126.8 |
||||||||
Corporate interest expense |
(11.7) |
— |
(11.7) |
||||||||
Operating earnings before taxes |
124.9 |
(9.8) |
115.1 |
||||||||
Tax expense on operating income |
39.1 |
(3.4) |
35.7 |
||||||||
Net operating income |
$ |
85.8 |
$ |
(6.4) |
$ |
79.4 |
|||||
Net operating income per diluted share |
$ |
.51 |
$ |
(.04) |
$ |
.47 |
The significant items in 4Q17 included adjustments arising from our comprehensive annual actuarial review of assumptions including
* See page 10 for the table of Net Operating Income Excluding Significant Items for the three months ended
Segment Results
Bankers Life markets and distributes a variety of insurance products to middle-income Americans at or near retirement through a dedicated field force of career agents. First-year collected premiums in 4Q17 were
Total collected premiums in 4Q17 were
Pre-tax operating earnings in 4Q17 compared to 4Q16 were down
The long-term care interest-adjusted benefit ratio was 73.1 percent in 4Q17, lower than the 4Q16 ratio of 76.0 percent. The 4Q17 ratio reflects no increase to the future loss reserve, given the outcome of the year-end 2016 actuarial review, compared to a
Pre-tax operating earnings in 4Q17 reflected a Medicare supplement benefit ratio of 70.7 percent, lower than the 4Q16 ratio of 71.2 percent. We currently expect the Medicare supplement benefit ratio to be in the range of 71 percent to 74 percent during 2018.
Washington National markets and distributes supplemental health and life insurance to middle-income consumers through a wholly-owned subsidiary and independent insurance agencies. First-year collected premiums in 4Q17 were
Total collected premiums from the segment's supplemental health block were up 4 percent in 4Q17 compared to 4Q16. Total collected premiums from this block in 2017 were
Pre-tax operating earnings in 4Q17 compared to 4Q16 were down
Colonial Penn markets primarily graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, the internet and telemarketing. First-year collected premiums in 4Q17 were
Total collected premiums were up 3 percent in 4Q17 compared to 4Q16. Total collected premiums in 2017 were
Pre-tax operating earnings in 4Q17 were
Recognizing the accounting standard related to deferred acquisition costs, the amount of our investment in new business during a particular period will have a significant impact on this segment's results. We expect this segment to report earnings in 2018 in the range of
Long-term care in run-off only includes the long-term care business that was recaptured in
Corporate Operations includes our investment advisory subsidiary and corporate expenses.
Pre-tax losses in 4Q17 were
Non-Operating Items
Net realized investment losses in 4Q17 were
During 4Q17 and 4Q16, we recognized increases in earnings of
During 4Q17 and 4Q16, we recognized increases in earnings of
In 4Q17, the valuation allowance for deferred tax assets and other tax items included: (i) a net increase to tax expense of
In 4Q16, we previously disclosed we had reached a settlement with the
Statutory (based on non-GAAP measures) and GAAP Capital Information
Our consolidated statutory risk-based capital ratio was estimated at 446% at
During the fourth quarter of 2017, we repurchased
Unrestricted cash and investments held by our holding company were
Book value per common share was
The debt-to-capital ratio was 15.9 percent and 16.9 percent at
CNO continues to expect free cash flow generation of approximately
Conference Call
The Company will host a conference call to discuss results on
About
|
|||||||
CONSOLIDATED BALANCE SHEET |
|||||||
(Dollars in millions) |
|||||||
(unaudited) |
|||||||
|
|
||||||
ASSETS |
|||||||
Investments: |
|||||||
Fixed maturities, available for sale, at fair value (amortized cost: 2017 - |
$ |
22,910.9 |
$ |
21,096.2 |
|||
Equity securities at fair value (cost: 2017 - |
511.7 |
584.2 |
|||||
Mortgage loans |
1,650.6 |
1,768.0 |
|||||
Policy loans |
116.0 |
112.0 |
|||||
Trading securities |
284.6 |
363.4 |
|||||
Investments held by variable interest entities |
1,526.9 |
1,724.3 |
|||||
Other invested assets |
853.4 |
589.5 |
|||||
Total investments |
27,854.1 |
26,237.6 |
|||||
Cash and cash equivalents - unrestricted |
578.4 |
478.9 |
|||||
Cash and cash equivalents held by variable interest entities |
178.9 |
189.3 |
|||||
Accrued investment income |
245.9 |
239.6 |
|||||
Present value of future profits |
359.6 |
401.8 |
|||||
Deferred acquisition costs |
1,026.8 |
1,044.7 |
|||||
Reinsurance receivables |
2,175.2 |
2,260.4 |
|||||
Income tax assets, net |
366.9 |
789.7 |
|||||
Assets held in separate accounts |
5.0 |
4.7 |
|||||
Other assets |
319.5 |
328.5 |
|||||
Total assets |
$ |
33,110.3 |
$ |
31,975.2 |
|||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
Liabilities: |
|||||||
Liabilities for insurance products: |
|||||||
Policyholder account balances |
$ |
11,220.7 |
$ |
10,912.7 |
|||
Future policy benefits |
11,521.3 |
10,953.3 |
|||||
Liability for policy and contract claims |
530.3 |
500.6 |
|||||
Unearned and advanced premiums |
261.7 |
282.5 |
|||||
Liabilities related to separate accounts |
5.0 |
4.7 |
|||||
Other liabilities |
751.8 |
611.4 |
|||||
Investment borrowings |
1,646.7 |
1,647.4 |
|||||
Borrowings related to variable interest entities |
1,410.7 |
1,662.8 |
|||||
Notes payable – direct corporate obligations |
914.6 |
912.9 |
|||||
Total liabilities |
28,262.8 |
27,488.3 |
|||||
Commitments and Contingencies |
|||||||
Shareholders' equity: |
|||||||
Common stock ( and outstanding: 2017 - 166,857,931; 2016 - 173,753,614) |
1.7 |
1.7 |
|||||
Additional paid-in capital |
3,073.3 |
3,212.1 |
|||||
Accumulated other comprehensive income |
1,006.7 |
622.4 |
|||||
Retained earnings |
765.8 |
650.7 |
|||||
Total shareholders' equity |
4,847.5 |
4,486.9 |
|||||
Total liabilities and shareholders' equity |
$ |
33,110.3 |
$ |
31,975.2 |
|
|||||||||||||||
CONSOLIDATED STATEMENT OF OPERATIONS |
|||||||||||||||
(Dollars in millions, except per share data) |
|||||||||||||||
(unaudited) |
|||||||||||||||
Three months ended |
Year ended |
||||||||||||||
|
|
||||||||||||||
2017 |
2016 |
2017 |
2016 |
||||||||||||
Revenues: |
|||||||||||||||
Insurance policy income |
$ |
660.1 |
$ |
654.1 |
$ |
2,647.3 |
$ |
2,601.1 |
|||||||
Net investment income: |
|||||||||||||||
General account assets |
325.1 |
315.6 |
1,285.4 |
1,204.1 |
|||||||||||
Policyholder and other special-purpose portfolios |
94.1 |
38.4 |
265.9 |
121.1 |
|||||||||||
Realized investment gains (losses): |
|||||||||||||||
Net realized investment gains (losses), excluding impairment losses |
2.6 |
(7.5) |
77.4 |
47.9 |
|||||||||||
Other-than-temporary impairments: |
|||||||||||||||
Total other-than-temporary impairment losses |
(4.6) |
(11.1) |
(21.9) |
(35.9) |
|||||||||||
Change in other-than-temporary impairment losses recognized in accumulated other comprehensive income |
— |
3.6 |
(.9) |
3.6 |
|||||||||||
Net impairment losses recognized |
(4.6) |
(7.5) |
(22.8) |
(32.3) |
|||||||||||
Loss on dissolution of variable interest entities |
— |
— |
(4.3) |
(7.3) |
|||||||||||
Total realized gains (losses) |
(2.0) |
(15.0) |
50.3 |
8.3 |
|||||||||||
Fee revenue and other income |
12.8 |
11.8 |
48.3 |
50.5 |
|||||||||||
Total revenues |
1,090.1 |
1,004.9 |
4,297.2 |
3,985.1 |
|||||||||||
Benefits and expenses: |
|||||||||||||||
Insurance policy benefits |
661.1 |
529.3 |
2,602.7 |
2,390.5 |
|||||||||||
Loss on reinsurance transaction |
— |
— |
— |
75.4 |
|||||||||||
Interest expense |
31.4 |
30.4 |
123.7 |
116.4 |
|||||||||||
Amortization |
58.0 |
71.7 |
239.3 |
253.3 |
|||||||||||
Loss on extinguishment of borrowings related to variable interest entities |
4.0 |
— |
9.5 |
— |
|||||||||||
Other operating costs and expenses |
210.2 |
192.8 |
841.5 |
796.3 |
|||||||||||
Total benefits and expenses |
964.7 |
824.2 |
3,816.7 |
3,631.9 |
|||||||||||
Income before income taxes |
125.4 |
180.7 |
480.5 |
353.2 |
|||||||||||
Income tax expense (benefit): |
|||||||||||||||
Tax expense on period income |
39.2 |
66.1 |
162.8 |
127.8 |
|||||||||||
Valuation allowance for deferred tax assets and other tax items |
157.1 |
(119.6) |
142.1 |
(132.8) |
|||||||||||
Net income (loss) |
$ |
(70.9) |
$ |
234.2 |
$ |
175.6 |
$ |
358.2 |
|||||||
Earnings per common share: |
|||||||||||||||
Basic: |
|||||||||||||||
Weighted average shares outstanding |
167,428,000 |
173,634,000 |
170,025,000 |
176,638,000 |
|||||||||||
Net income (loss) |
$ |
(.42) |
$ |
1.35 |
$ |
1.03 |
$ |
2.03 |
|||||||
Diluted: |
|||||||||||||||
Weighted average shares outstanding |
167,428,000 |
175,173,000 |
172,144,000 |
178,323,000 |
|||||||||||
Net income (loss) |
$ |
(.42) |
$ |
1.34 |
$ |
1.02 |
$ |
2.01 |
|
|||||||
SEGMENT OPERATING RESULTS |
|||||||
(Dollars in millions, except per share data) |
|||||||
Year ended |
|||||||
|
|||||||
2017 |
2016 |
||||||
Adjusted EBIT (4): |
|||||||
Bankers Life |
$ |
418.9 |
$ |
397.9 |
|||
Washington National |
98.3 |
102.9 |
|||||
Colonial Penn: |
|||||||
Inforce business (5) |
68.8 |
54.4 |
|||||
New business (5) |
(46.2) |
(52.7) |
|||||
Total Colonial Penn |
22.6 |
1.7 |
|||||
Long-term care in run-off |
1.7 |
(3.9) |
|||||
Adjusted EBIT from business segments |
541.5 |
498.6 |
|||||
Corporate Operations, excluding corporate interest expense |
(40.3) |
(42.5) |
|||||
Adjusted EBIT |
501.2 |
456.1 |
|||||
Corporate interest expense |
(46.5) |
(45.8) |
|||||
Operating earnings before taxes |
454.7 |
410.3 |
|||||
Tax expense on operating income |
153.8 |
147.8 |
|||||
Net operating income (1) |
300.9 |
262.5 |
|||||
Net realized investment gains (net of related amortization) |
49.3 |
7.6 |
|||||
Fair value changes in embedded derivative liabilities (net of related amortization) |
(2.5) |
9.6 |
|||||
Fair value changes and amendment related to agent deferred compensation plan |
(12.2) |
3.1 |
|||||
Loss on reinsurance transaction |
— |
(75.4) |
|||||
Other |
(8.8) |
(2.0) |
|||||
Non-operating income (loss) before taxes |
25.8 |
(57.1) |
|||||
Income tax expense (benefit): |
|||||||
On non-operating income (loss) |
9.0 |
(20.0) |
|||||
Valuation allowance for deferred tax assets and other tax items |
142.1 |
(132.8) |
|||||
Net non-operating income (loss) |
(125.3) |
95.7 |
|||||
Net income |
$ |
175.6 |
$ |
358.2 |
|||
Per diluted share: |
|||||||
Net operating income |
$ |
1.75 |
$ |
1.47 |
|||
Net realized investment gains (net of related amortization and taxes) |
.19 |
.03 |
|||||
Fair value changes in embedded derivative liabilities (net of related amortization and taxes) |
(.01) |
.04 |
|||||
Fair value changes and amendment related to agent deferred compensation plan (net of taxes) |
(.05) |
.01 |
|||||
Loss on reinsurance transaction (net of taxes) |
— |
(.27) |
|||||
Valuation allowance for deferred tax assets and other tax items |
(.83) |
.74 |
|||||
Other |
(.03) |
(.01) |
|||||
Net income |
$ |
1.02 |
$ |
2.01 |
|
|||||||||||
NET OPERATING INCOME EXCLUDING SIGNIFICANT ITEMS* |
|||||||||||
(Dollars in millions, except per share data) |
|||||||||||
Three months ended |
|||||||||||
|
|||||||||||
Actual results |
Significant items |
Excluding significant items |
|||||||||
Net Operating Income (1): |
|||||||||||
Bankers Life |
$ |
138.9 |
$ |
(48.2) |
$ |
90.7 |
|||||
Washington National |
29.9 |
— |
29.9 |
||||||||
Colonial Penn |
4.6 |
2.5 |
7.1 |
||||||||
Long-term care in run-off |
(3.9) |
2.6 |
(1.3) |
||||||||
Adjusted EBIT from business segments |
169.5 |
(43.1) |
126.4 |
||||||||
Corporate Operations, excluding corporate interest expense |
(23.0) |
5.5 |
(17.5) |
||||||||
Adjusted EBIT (4) |
146.5 |
(37.6) |
108.9 |
||||||||
Corporate interest expense |
(11.5) |
— |
(11.5) |
||||||||
Operating earnings before taxes |
135.0 |
(37.6) |
97.4 |
||||||||
Tax expense on operating income |
50.1 |
(13.5) |
36.6 |
||||||||
Net operating income |
$ |
84.9 |
$ |
(24.1) |
$ |
60.8 |
|||||
Net operating income per diluted share |
$ |
.49 |
$ |
(.14) |
$ |
.35 |
* This table summarizes the financial impact of significant items (as described in the segment results section of this press release) on our 4Q16 net operating income.
|
|||||||
FIRST-YEAR COLLECTED PREMIUMS |
|||||||
(Dollars in millions) |
|||||||
Three months ended |
|||||||
|
|||||||
2017 |
2016 |
||||||
Bankers Life: |
|||||||
Medicare supplement |
$ |
17.4 |
$ |
19.3 |
|||
Long-term care |
3.9 |
4.2 |
|||||
Supplemental health |
1.2 |
1.4 |
|||||
Other health |
.2 |
.1 |
|||||
Life |
32.9 |
33.7 |
|||||
Annuity |
270.8 |
283.4 |
|||||
Total |
326.4 |
342.1 |
|||||
Washington National: |
|||||||
Supplemental health and other health |
18.1 |
17.7 |
|||||
Life |
1.2 |
1.4 |
|||||
Annuity |
— |
.2 |
|||||
Total |
19.3 |
19.3 |
|||||
Colonial Penn: |
|||||||
Life |
11.6 |
13.2 |
|||||
Total |
11.6 |
13.2 |
|||||
Total first-year collected premiums from segments |
$ |
357.3 |
$ |
374.6 |
TOTAL COLLECTED PREMIUMS |
|||||||
(Dollars in millions) |
|||||||
Three months ended |
|||||||
|
|||||||
2017 |
2016 |
||||||
Bankers Life: |
|||||||
Medicare supplement |
$ |
190.8 |
$ |
191.2 |
|||
Long-term care |
108.9 |
114.7 |
|||||
Supplemental health |
5.8 |
5.5 |
|||||
Other health |
1.5 |
1.5 |
|||||
Life |
117.0 |
113.8 |
|||||
Annuity |
272.3 |
284.9 |
|||||
Total |
696.3 |
711.6 |
|||||
Washington National: |
|||||||
Supplemental health and other health |
147.7 |
142.1 |
|||||
Medicare supplement |
12.9 |
14.9 |
|||||
Life |
7.7 |
7.7 |
|||||
Annuity |
.3 |
.5 |
|||||
Total |
168.6 |
165.2 |
|||||
Colonial Penn: |
|||||||
Life |
71.5 |
69.2 |
|||||
Medicare supplement and other health |
.5 |
.6 |
|||||
Total |
72.0 |
69.8 |
|||||
Long-term care in run-off: |
|||||||
Long-term care |
4.0 |
4.7 |
|||||
Total |
4.0 |
$ |
4.7 |
||||
Total collected premiums from segments |
$ |
940.9 |
$ |
951.3 |
|
|||||||
NEW ANNUALIZED PREMIUMS FOR LIFE AND HEALTH PRODUCTS (2) |
|||||||
(Dollars in millions) |
|||||||
Three months ended |
|||||||
|
|||||||
2017 |
2016 |
||||||
Bankers Life: |
|||||||
Medicare supplement |
$ |
20.0 |
$ |
23.9 |
|||
Long-term care |
5.1 |
5.5 |
|||||
Supplemental health and other health |
1.9 |
1.6 |
|||||
Life |
16.5 |
17.0 |
|||||
Total |
43.5 |
48.0 |
|||||
Washington National: |
|||||||
Supplemental health |
24.8 |
25.2 |
|||||
Life |
2.3 |
1.8 |
|||||
Total |
27.1 |
27.0 |
|||||
Colonial Penn: |
|||||||
Life |
14.8 |
14.7 |
|||||
Total |
14.8 |
14.7 |
|||||
Total new annualized premiums |
$ |
85.4 |
$ |
89.7 |
ANNUITY ACCOUNT VALUES |
|||||||
(Dollars in millions) |
|||||||
|
|||||||
2017 |
2016 |
||||||
Bankers Life |
$ |
8,163.3 |
$ |
7,788.5 |
|||
Washington National |
378.2 |
413.7 |
|||||
Total |
$ |
8,541.5 |
$ |
8,202.2 |
|
|||||
BENEFIT RATIOS ON MAJOR HEALTH LINES OF BUSINESS |
|||||
Three months ended |
|||||
|
|||||
2017 |
2016 |
||||
Bankers Life: |
|||||
Medicare supplement: |
|||||
Earned premium |
|
|
|||
Benefit ratio (7) |
70.7 |
% |
71.2 |
% |
|
Long-term care: |
|||||
Earned premium |
|
|
|||
Benefit ratio (7) |
135.3 |
% |
134.7 |
% |
|
Interest-adjusted benefit ratio (a non-GAAP measure) (8) |
73.1 |
% |
76.0 |
% |
|
Washington National: |
|||||
Medicare supplement: |
|||||
Earned premium |
|
|
|||
Benefit ratio (7) |
67.0 |
% |
64.8 |
% |
|
Supplemental health: |
|||||
Earned premium |
|
|
|||
Benefit ratio (7) |
80.7 |
% |
81.0 |
% |
|
Interest-adjusted benefit ratio (a non-GAAP measure) (8) |
56.6 |
% |
57.0 |
% |
|
Long-term care in run-off: |
|||||
Long-term care: |
|||||
Earned premium |
|
|
|||
Benefit ratio (7) |
251.7 |
% |
365.8 |
% |
|
Interest-adjusted benefit ratio (a non-GAAP measure) (8) |
82.2 |
% |
213.5 |
% |
NOTES
(1) Management believes that an analysis of Net income applicable to common stock before: (i) net realized investment gains or losses, net of related amortization and taxes; (ii) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (iii) fair value changes and amendment related to the agent deferred compensation plan, net of taxes, (iv) changes in the valuation allowance for deferred tax assets and other tax items; and (v) other non-operating items consisting primarily of earnings attributable to variable interest entities, net of taxes ("Net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the company's underlying fundamentals. Net realized investment gains or losses include: (i) gains or losses on the sales of investments; (ii) other-than-temporary impairments recognized through net income; and (iii) changes in fair value of certain fixed maturity investments with embedded derivatives. A reconciliation of Net operating income to Net income applicable to common stock is provided in the tables on pages 2 and 9. Additional information concerning this non-GAAP measure is included in our periodic filings with the
(2) Measured by new annualized premium for life and health products, which includes 10% of single premium whole life deposits and 100% of all other premiums (excluding annuities). Medicare Advantage sales are not comparable to other sales and are therefore excluded in all periods.
(3) Book value per diluted share reflects the potential dilution that could occur if outstanding stock options were exercised, restricted stock and performance units were vested and convertible securities were converted. The dilution from options, restricted shares and performance units is calculated using the treasury stock method. Under this method, we assume the proceeds from the exercise of the options (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the closing market price on the last day of the period. The dilution from convertible securities is calculated assuming the securities were converted on the last day of the period. In addition, the calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. In addition, the value of capital used to calculate this non-GAAP measure at
(4) Management believes that an analysis of earnings before net realized investment gains (losses), fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, fair value changes and amendment related to the agent deferred compensation plan, other non-operating items, corporate interest expense and taxes ("Adjusted EBIT," a non-GAAP financial measure) provides a clearer comparison of the operating results of the company quarter-over-quarter because these items are unrelated to the company's underlying fundamentals. A reconciliation of Adjusted EBIT to Net Income applicable to common stock is provided in the tables on pages 2 and 9.
(5) Management believes that an analysis of Adjusted EBIT for Colonial Penn, separated between inforce and new business, provides increased clarity for this segment as the vast majority of the costs to generate new business in this segment are not deferrable and Adjusted EBIT will fluctuate based on management's decisions on how much marketing costs to incur in each period. Adjusted EBIT from new business includes pre-tax revenues and expenses associated with new sales of our insurance products during the first year after the sale is completed. Adjusted EBIT from inforce business includes all pre-tax revenues and expenses associated with sales of insurance products that were completed more than one year before the end of the reporting period. The allocation of certain revenues and expenses between new and inforce business is based on estimates, which we believe are reasonable.
(6) The calculation of this non-GAAP measure differs from the corresponding GAAP measure because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in the unrealized appreciation (depreciation) of our investments. In addition, the value of capital used to calculate this non-GAAP measure at
(7) The benefit ratio is calculated by dividing the related product's insurance policy benefits by insurance policy income.
(8) The interest-adjusted benefit ratio (a non-GAAP measure) is calculated by dividing the product's insurance policy benefits less imputed interest income on the accumulated assets backing the insurance liabilities by insurance policy income. Interest income is an important factor in measuring the performance of longer duration health products. The net cash flows generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases), which will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in the change in reserve will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio, which includes the effect of interest income, is useful in analyzing product performance. Additional information concerning this non-GAAP measure is included in our periodic filings with the
Cautionary Statement Regarding Forward-Looking Statements. Our statements, trend analyses and other information contained in this press release relative to markets for
View original content:http://www.prnewswire.com/news-releases/cno-financial-group-reports-fourth-quarter-and-full-year-2017-results-300598257.html
SOURCE
Service Corporation International Announces Fourth Quarter 2017 Financial Results And Outlook For 2018
Rep. Velazquez Issues Statement on President Trump’s FY 2019 Budget Proposal
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News